Starton Therapeutics (Starton Therapeutics) Scaled Net Operating Assets : -1.85 (As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Starton Therapeutics's operating assets for the quarter that ended in Jun. 2023 was $2.90 Mil. Starton Therapeutics's operating liabilities for the quarter that ended in Jun. 2023 was $6.85 Mil. Starton Therapeutics's Total Assets for the quarter that ended in Mar. 2023 was $2.14 Mil. Therefore, Starton Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2023 was -1.85.

Starton Therapeutics Scaled Net Operating Assets Historical Data

The historical data trend for Starton Therapeutics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Scaled Net Operating Assets Chart

Starton Therapeutics Annual Data

Trend

Mar21

Mar22

Mar23

Scaled Net Operating Assets

0.06

-0.18

-1.50

Starton Therapeutics Quarterly Data
	Mar21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23
Scaled Net Operating Assets	Get a 7-Day Free Trial			-	-	-	-1.82	-1.85

Competitive Comparison of Starton Therapeutics's Scaled Net Operating Assets

For the Biotechnology subindustry, Starton Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Starton Therapeutics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Starton Therapeutics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Starton Therapeutics's Scaled Net Operating Assets falls into.

Starton Therapeutics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Starton Therapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2023 )
=	(Operating Assets (A: Mar. 2023 )	-	Operating Liabilities (A: Mar. 2023 ))	/	Total Assets (A: Mar. 2022 )
=	(1.995	-	5.844)	/	2.574
=	-1.50

where

	Operating Assets		(A: Mar. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2.137	-	0.142
=	1.995

	Operating Liabilities		(A: Mar. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	7.456	-	1.451	-	0.161
=	5.844

Starton Therapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2023 )
=	(Operating Assets (Q: Jun. 2023 )	-	Operating Liabilities (Q: Jun. 2023 ))	/	Total Assets (Q: Mar. 2023 )
=	(2.898	-	6.847)	/	2.137
=	-1.85

where

	Operating Assets		(Q: Jun. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	4.243	-	1.345
=	2.898

	Operating Liabilities		(Q: Jun. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	8.425	-	1.421	-	0.157
=	6.847

Starton Therapeutics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Starton Therapeutics (Starton Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

215 College Road, Suite No.300, Paramus, NJ, USA, 07652

Website

https://www.startontx.com

Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines